{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:40:18Z","timestamp":1791909618816,"version":"4.3.4"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bcp.2024.116062","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T21:10:48Z","timestamp":1708117848000},"page":"116062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8966-5070","authenticated-orcid":false,"given":"Elena","family":"Kaschina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilyara","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 Pt2","key":"10.1016\/j.bcp.2024.116062_b0005","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/00004872-199917121-00001","article-title":"The angiotensin type 2 receptor: variations on an enigmatic theme","volume":"17","author":"Unger","year":"1999","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.bcp.2024.116062_b0010","first-page":"415","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0015","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/pharmrev.120.000281","article-title":"The angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target","volume":"74","author":"Steckelings","year":"2022","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.bcp.2024.116062_b0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13069-015-0023-z","article-title":"Modulation of angiotensin II signaling in the prevention of fibrosis","volume":"23","author":"Murphy","year":"2015","journal-title":"Fibrog. Tissue Repair"},{"key":"10.1016\/j.bcp.2024.116062_b0025","series-title":"The Protective Arm of the Renin Angiotensin System - Functional Aspects and Therapeutic Implications","year":"2015"},{"issue":"Pt A","key":"10.1016\/j.bcp.2024.116062_b0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phrs.2017.07.008","article-title":"AT2 receptors in cardiovascular and renal diseases","volume":"125","author":"Kaschina","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.bcp.2024.116062_b0035","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3389\/fphar.2017.00564","article-title":"Anti-fibrotic Potential of AT2 Receptor Agonists","volume":"31","author":"Wang","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0040","doi-asserted-by":"crossref","first-page":"e13280","DOI":"10.1111\/apha.13280","article-title":"Anti-fibrotic mechanisms of angiotensin AT2 -receptor stimulation","volume":"227","author":"Sumners","year":"2019","journal-title":"Acta Physiol (Oxf.)"},{"issue":"6","key":"10.1016\/j.bcp.2024.116062_b0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41569-022-00678-w","article-title":"Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications","volume":"19","author":"Carnevale","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0050","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol. Rev."},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2024.116062_b0055","first-page":"41723","article-title":"Bone lessons from Marfan syndrome and related disorders: fibrillin, TGF-B and BMP at the balance of too long and too short","volume":"10","author":"Loeys","year":"2013","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"17","key":"10.1016\/j.bcp.2024.116062_b0060","article-title":"Cytokines in Abdominal Aortic Aneurysm: Master Regulators With Clinical Application","volume":"25","author":"Puchenkova","year":"2022","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.bcp.2024.116062_b0065","article-title":"Angiotensin II receptor subtypes and cardiac function","volume":"15 Suppl D:98\u2013103","author":"de Gasparo","year":"1994","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0070","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0008-6363(99)00145-5","article-title":"The renin-angiotensin system and experimental heart failure","volume":"43","author":"Wollert","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2024.116062_b0075","article-title":"Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases","volume":"14\u201328;83(12):1182\u201391","author":"Matsubara","year":"1998","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bcp.2024.116062_b0080","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.HYP.0000159192.93968.8f","article-title":"Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age","volume":"45","author":"Carey","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2024.116062_b0085","doi-asserted-by":"crossref","unstructured":"Widdop RE, Jones ES, Hannan RE, Gaspari TA. Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol. 2003 Nov;140(5):809-24. doi: 10.1038\/sj.bjp.0705448. Epub 2003 Oct 6. PMID: 14530223; PMCID: PMC1574085.","DOI":"10.1038\/sj.bjp.0705448"},{"issue":"7","key":"10.1016\/j.bcp.2024.116062_b0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11906-014-0441-0","article-title":"AT2 receptors targeting cardiac protection post-myocardial infarction","volume":"16","author":"Kaschina","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"issue":"11","key":"10.1016\/j.bcp.2024.116062_b0095","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/s41440-023-01424-6","article-title":"The (pro)renin receptor as a pharmacological target in cardiorenal diseaes","volume":"46","author":"Funke-Kaiser","year":"2023","journal-title":"Hypertens. Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9440(10)64571-3","article-title":"Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study","volume":"157","author":"Busche","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI117675","article-title":"Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction","volume":"95","author":"Nio","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bcp.2024.116062_b0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3317\/jraas.2000.039","article-title":"Effects of losartan on haemodynamic parameters and angiotensin receptor mRNA levels in rat heart after myocardial infarction","volume":"1","author":"Zhu","year":"2000","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"8","key":"10.1016\/j.bcp.2024.116062_b0115","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1440-1681.2004.04034.x","article-title":"Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium","volume":"31","author":"Lax","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116062_b0120","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.4049\/jimmunol.0903681","article-title":"Identification of noncytotoxic and IL-10-producing CD8+AT2R+ T cell population in response to ischemic heart injury","volume":"185","author":"Curato","year":"2010","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116062_b0125","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/stem.171","article-title":"Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance","volume":"27","author":"Altarche-Xifr\u00f3","year":"2009","journal-title":"Stem Cells"},{"issue":"10","key":"10.1016\/j.bcp.2024.116062_b0130","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/01.CIR.92.10.3105","article-title":"Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure","volume":"92","author":"Pieruzzi","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0135","first-page":"323","article-title":"Differential distribution of angiotensin AT2 receptors in the normal and failing human heart","volume":"284","author":"Wharton","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2024.116062_b0140","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/oxfordjournals.eurheartj.a015008","article-title":"Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction","volume":"17","author":"Rogg","year":"1996","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2024.116062_b0145","article-title":"Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects","volume":"16 Suppl N:86\u201391","author":"Regitz-Zagrosek","year":"1995","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0008-6363(00)00008-0","article-title":"Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure","volume":"46","author":"Matsumoto","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.bcp.2024.116062_b0155","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.95.5.1193","article-title":"Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium","volume":"95","author":"Asano","year":"1997","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bcp.2024.116062_b0160","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.RES.83.10.1035","article-title":"Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression","volume":"83","author":"Tsutsumi","year":"1998","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bcp.2024.116062_b0165","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1161\/01.CIR.95.5.1201","article-title":"AT1 and AT2 angiotensin receptor gene expression in human heart failure","volume":"95","author":"Haywood","year":"1997","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bcp.2024.116062_b0170","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1161\/01.CIR.96.11.3954","article-title":"Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism","volume":"96","author":"Ohkubo","year":"1997","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.bcp.2024.116062_b0175","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1006\/jmcc.1996.0168","article-title":"Localization of the angiotensin II receptor subtypes in the human atrium","volume":"28","author":"Brink","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116062_b0180","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1097\/00004872-199312050-00096","article-title":"The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts","volume":"11","author":"Wiemer","year":"1993","journal-title":"J. Hypertens. Suppl."},{"issue":"3 Pt 2","key":"10.1016\/j.bcp.2024.116062_b0185","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/01.HYP.0000048340.53100.43","article-title":"Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling","volume":"41","author":"Oishi","year":"2003","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.bcp.2024.116062_b0190","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/01.CIR.0000033826.52681.37","article-title":"Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction","volume":"106","author":"Ichihara","year":"2002","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.bcp.2024.116062_b0195","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1161\/01.CIR.0000072763.98069.B4","article-title":"Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice","volume":"107","author":"Adachi","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bcp.2024.116062_b0200","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.HYP.0000100445.80029.8E","article-title":"Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice","volume":"42","author":"Brede","year":"2003","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.CIR.0000020014.14176.6D","article-title":"Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction","volume":"106","author":"Yang","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0210","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1081\/JCMR-200053461","article-title":"The angiotensin II type 2 receptor and improved adjacent region function post-MI","volume":"7","author":"Bove","year":"2005","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"3","key":"10.1016\/j.bcp.2024.116062_b0215","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.HYP.0000115924.94236.91","article-title":"Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling","volume":"43","author":"Bove","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2024.116062_b0220","doi-asserted-by":"crossref","unstructured":"Qi Y, Li H, Shenoy V, Li Q, Wong F, Zhang L, Raizada MK, Sumners C, Katovich MJ. Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury. Exp Physiol. 2012 Jan;97(1):89-101. doi: 10.1113\/expphysiol.2011.060673. Epub 2011 Oct 3. PMID: 21967903; PMCID: PMC3619662.","DOI":"10.1113\/expphysiol.2011.060673"},{"issue":"3","key":"10.1016\/j.bcp.2024.116062_b0225","first-page":"H1004","article-title":"Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling","volume":"290","author":"Voros","year":"2006","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2024.116062_b0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s003950050226","article-title":"AT1 receptor blockade in experimental myocardial ischemia\/reperfusion","volume":"93","author":"Jalowy","year":"1998","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0235","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lfs.2006.08.033","article-title":"AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling","volume":"80","author":"Oishi","year":"2006","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0240","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.HYP.36.4.506","article-title":"Enhanced expression of angiotensin II type 2 receptor, inositol 1,4, 5-trisphosphate receptor, and protein kinase cepsilon during cardioprotection induced by angiotensin II type 2 receptor blockade","volume":"36","author":"Xu","year":"2000","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0245","first-page":"H1206","article-title":"AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts","volume":"282","author":"Xu","year":"2002","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.bcp.2024.116062_b0250","unstructured":"Jugdutt BI. Apoptosis after reperfused myocardial infarction: Role of angiotensin II. Exp Clin Cardiol. 2004 Winter;9(4):219-28. PMID: 19641712; PMCID: PMC2716282."},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0255","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/jmcc.1997.0607","article-title":"AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction","volume":"30","author":"Kuizinga","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"24","key":"10.1016\/j.bcp.2024.116062_b0260","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm049715t","article-title":"Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist","volume":"47","author":"Wan","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116062_b0265","first-page":"69","article-title":"Nonpeptide AT2 Receptor Agonists","volume":"51","author":"Larhed","year":"2016","journal-title":"Med. Chem. Rev."},{"key":"10.1016\/j.bcp.2024.116062_b0270","doi-asserted-by":"crossref","unstructured":"Kaschina E, Grzesiak A, Li J, Foryst-Ludwig A, Timm M, Rompe F, Sommerfeld M, Kemnitz UR, Curato C, Namsolleck P, Tsch\u00f6pe C, Hallberg A, Alterman M, Hucko T, Paetsch I, Dietrich T, Schnackenburg B, Graf K, Dahl\u00f6f B, Kintscher U, Unger T, Steckelings UM. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation. 2008 Dec 9;118(24):2523-32. doi: 10.1161\/CIRCULATIONAHA.108.784868. Epub 2008 Nov 24. Erratum in: Circulation. 2010 Jun 29;121(25):e459. PMID: 19029468.","DOI":"10.1161\/CIRCULATIONAHA.108.784868"},{"issue":"3","key":"10.1016\/j.bcp.2024.116062_b0275","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1161\/HYPERTENSIONAHA.113.02522","article-title":"Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1\/matrix metalloproteinase 9 axis and transforming growth factor \u03b21 in the rat heart","volume":"63","author":"Lauer","year":"2014","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12012-020-09590-6","article-title":"The Protective Effects of Compound 21 and Valsartan in Isoproterenol-Induced Myocardial Injury in Rats","volume":"21","author":"Ulutas","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/CBB:43:1:045","article-title":"Angiotensin AT2 receptor deficiency after myocardial infarction: its effects on cardiac function and fibrosis depend on the stimulus","volume":"43","author":"Tsch\u00f6pe","year":"2005","journal-title":"Cell Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0290","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/FJC.0b013e3182444110","article-title":"A nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in mice","volume":"59","author":"Jehle","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116062_b0295","doi-asserted-by":"crossref","unstructured":"Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest. 1997 Apr 15;99(8):1926-35. doi: 10.1172\/JCI119360. PMID: 9109437; PMCID: PMC508017.","DOI":"10.1172\/JCI119360"},{"issue":"1 Pt 2","key":"10.1016\/j.bcp.2024.116062_b0300","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/01.HYP.31.1.349","article-title":"AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism","volume":"31","author":"Gohlke","year":"1998","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0305","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00041552-200501000-00011","article-title":"Update on the role of the AT2 receptor","volume":"14","author":"Carey","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0310","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/cphy.c100053","article-title":"The kallikrein-kinin system as a regulator of cardiovascular and renal function","volume":"1","author":"Rhaleb","year":"2011","journal-title":"Compr. Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116062_b0315","first-page":"H3372","article-title":"Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling","volume":"293","author":"Isbell","year":"2007","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.bcp.2024.116062_b0320","doi-asserted-by":"crossref","unstructured":"Xu Y, Hu X, Wang L, Jiang Z, Liu X, Yu H, Zhang Z, Chen H, Chen H, Steinhoff G, Li J, Jian'an Wang. Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair. PLoS One. 2013 Dec 10;8(12):e82997. doi: 10.1371\/journal.pone.0082997. PMID: 24340072; PMCID: PMC3858344.","DOI":"10.1371\/journal.pone.0082997"},{"key":"10.1016\/j.bcp.2024.116062_b0325","doi-asserted-by":"crossref","unstructured":"Xu J, Sun Y, Carretero OA, Zhu L, Harding P, Shesely EG, Dai X, Rhaleb NE, Peterson E, Yang XP. Effects of cardiac overexpression of the angiotensin II type 2 receptor on remodeling and dysfunction in mice post-myocardial infarction. Hypertension. 2014 Jun;63(6):1251-9. doi: 10.1161\/HYPERTENSIONAHA.114.03247. Epub 2014 Apr 14. PMID: 24732892; PMCID: PMC4031246.","DOI":"10.1161\/HYPERTENSIONAHA.114.03247"},{"issue":"19","key":"10.1016\/j.bcp.2024.116062_b0330","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.CIR.0000128696.12245.57","article-title":"Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries","volume":"109","author":"Batenburg","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0335","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11897-017-0343-y","article-title":"From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities","volume":"14","author":"Suthahar","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2024.116062_b0340","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/me.2003-0053","article-title":"Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells","volume":"18","author":"Wu","year":"2004","journal-title":"Mol. Endocrinol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0345","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/cphy.c150006","article-title":"Pathophysiology of Myocardial Infarction","volume":"5","author":"Frangogiannis","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bcp.2024.116062_b0350","first-page":"1","article-title":"IL-6 signal transduction and its physiological roles: the signal orchestration model","volume":"149","author":"Kamimura","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2024.116062_b0355","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/S0735-1097(01)01287-6","article-title":"Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3- symporter in the rat heart after myocardial infarction","volume":"37","author":"Sandmann","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0360","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.109.147843","article-title":"Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB","volume":"55","author":"Rompe","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2024.116062_b0365","doi-asserted-by":"crossref","unstructured":"Mel\u00e9ndez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension. 2010 Aug;56(2):225-31. doi: 10.1161\/HYPERTENSIONAHA.109.148635. Epub 2010 Jul 6. PMID: 20606113; PMCID: PMC2921860.","DOI":"10.1161\/HYPERTENSIONAHA.109.148635"},{"issue":"13","key":"10.1016\/j.bcp.2024.116062_b0370","doi-asserted-by":"crossref","first-page":"12239","DOI":"10.1074\/jbc.M413284200","article-title":"Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling","volume":"280","author":"Zhang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116062_b0375","doi-asserted-by":"crossref","unstructured":"Skorska A, von Haehling S, Ludwig M, Lux CA, Gaebel R, Kleiner G, Klopsch C, Dong J, Curato C, Altarche-Xifr\u00f3 W, Slavic S, Unger T, Steinhoff G, Li J, David R. The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function. J Cell Mol Med. 2015 Aug;19(8):1975-85. doi: 10.1111\/jcmm.12574. Epub 2015 May 20. PMID: 25991381; PMCID: PMC4549048.","DOI":"10.1111\/jcmm.12574"},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0380","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08037050310001057","article-title":"Angiotensin AT1\/AT2 receptors: regulation, signalling and function","volume":"12","author":"Kaschina","year":"2003","journal-title":"Blood Press."},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0385","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11906-013-0416-6","article-title":"AT(2) receptor and tissue injury: therapeutic implications","volume":"16","author":"Namsolleck","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0390","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/CS20130601","article-title":"Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice","volume":"128","author":"Valero-Esquitino","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0395","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/1381612826666200115092015","article-title":"Emerging Role of Angiotensin AT2 Receptor in Anti-Inflammation: An Update","volume":"26","author":"Patel","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0400","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/HYPERTENSIONAHA.111.185496","article-title":"Direct angiotensin II type 2 receptor stimulation in N\u03c9-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling","volume":"59","author":"Paulis","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0405","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/HYPERTENSIONAHA.111.180158","article-title":"Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats","volume":"59","author":"Rehman","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2024.116062_b0410","doi-asserted-by":"crossref","unstructured":"Bruce E, Shenoy V, Rathinasabapathy A, Espejo A, Horowitz A, Oswalt A, Francis J, Nair A, Unger T, Raizada MK, Steckelings UM, Sumners C, Katovich MJ. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. Br J Pharmacol. 2015 May;172(9):2219-31. doi: 10.1111\/bph.13044. Epub 2015 Feb 27. PMID: 25522140; PMCID: PMC4403089.","DOI":"10.1111\/bph.13044"},{"issue":"24","key":"10.1016\/j.bcp.2024.116062_b0415","doi-asserted-by":"crossref","first-page":"13678","DOI":"10.3390\/ijms222413678","article-title":"Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension","volume":"22","author":"Castoldi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.bcp.2024.116062_b0420","doi-asserted-by":"crossref","first-page":"14039","DOI":"10.3390\/ijms232214039","article-title":"The Novel AT2 Receptor Agonist \u03b2-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116062_b0425","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1161\/01.CIR.104.3.346","article-title":"Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension","volume":"104","author":"Ichihara","year":"2001","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.bcp.2024.116062_b0430","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s00018-006-6085-8","article-title":"Role of transforming growth factor-beta in the progression of heart failure","volume":"63","author":"Lim","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.bcp.2024.116062_b0435","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-beta1 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.bcp.2024.116062_b0440","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/HYPERTENSIONAHA.115.05204","article-title":"AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy","volume":"65","author":"Koulis","year":"2015","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.bcp.2024.116062_b0445","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/HYPERTENSIONAHA.118.11168","article-title":"AT2R (Angiotensin AT2 Receptor) Agonist, Compound 21, Prevents Abdominal Aortic Aneurysm Progression in the Rat","volume":"72","author":"Lange","year":"2018","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.bcp.2024.116062_b0450","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1096\/fj.201902506R","article-title":"The anti-fibrotic actions of relaxin are mediated through AT2 R-associated protein phosphatases via RXFP1-AT2 R functional crosstalk in human cardiac myofibroblasts","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2024.116062_b0455","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/dvdy.24554","article-title":"Transforming growth factor-\u03b2, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition","volume":"247","author":"Santibanez","year":"2018","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bcp.2024.116062_b0460","doi-asserted-by":"crossref","unstructured":"Chow BSM, Kocan M, Shen M, Wang Y, Han L, Chew JY, Wang C, Bosnyak S, Mirabito-Colafella KM, Barsha G, Wigg B, Johnstone EKM, Hossain MA, Pfleger KDG, Denton KM, Widdop RE, Summers RJ, Bathgate RAD, Hewitson TD, Samuel CS. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis. J Am Soc Nephrol. 2019 Nov;30(11):2191-2207. doi: 10.1681\/ASN.2019060597. Epub 2019 Sep 11. PMID: 31511361; PMCID: PMC6830801.","DOI":"10.1681\/ASN.2019060597"},{"issue":"18","key":"10.1016\/j.bcp.2024.116062_b0465","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2217\/pgs-2016-0127","article-title":"Pathophysiology of aortic aneurysm: insights from human genetics and mouse models","volume":"17","author":"Wilson NK, Gould RA, Gallo MacFarlane E, Consortium ML","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0470","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.atherosclerosis.2009.01.003","article-title":"Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components","volume":"205","author":"Kaschina","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bcp.2024.116062_b0475","unstructured":"Wang C, Wang W, Du M, Liu X, Xue S. Characterization and functional elucidation of CD8+AT2+ lymphocytes in human thoracic aortic aneurysm. Int J Clin Exp Pathol. 2017 Jul 1;10(7):7427-7433. PMID: 31966585; PMCID: PMC6965229."},{"key":"10.1016\/j.bcp.2024.116062_b0480","unstructured":"Wang C, Wu T, Hu X, Huang R, Lian F, Wang W, Feng Y, Xie B, Hu Z, Zhai X, Liu J, Gu J, Chen Y, Li J, Xue S. Identification and characterization of CD4(+)AT2(+) T lymphocyte population in human thoracic aortic aneurysm. Am J Transl Res. 2015 Feb 15;7(2):232-41. PMID: 25901193; PMCID: PMC4399088."},{"issue":"6","key":"10.1016\/j.bcp.2024.116062_b0485","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00004872-200106000-00012","article-title":"Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion","volume":"19","author":"Bonnet","year":"2001","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.bcp.2024.116062_b0490","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1096\/fj.02-0755fje","article-title":"Control of dendritic cell differentiation by angiotensin II","volume":"17","author":"Nahmod","year":"2003","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.bcp.2024.116062_b0495","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/ajh\/hpac083","article-title":"AT2 Receptor Stimulation Inhibits Vascular Smooth Muscle Cell Senescence Induced by Angiotensin II and Hyperglycemia","volume":"35","author":"Bai","year":"2022","journal-title":"Am. J. Hypertens."},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0500","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0704331","article-title":"Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis","volume":"134","author":"Daugherty","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0505","doi-asserted-by":"crossref","first-page":"e61849","DOI":"10.1371\/journal.pone.0061849","article-title":"PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism","volume":"8","author":"Daugherty","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116062_b0510","doi-asserted-by":"crossref","unstructured":"Xue F, Yang J, Cheng J, Sui W, Cheng C, Li H, Zhang M, Zhang J, Xu X, Ma J, Lu L, Xu J, Zhang M, Zhang Y, Zhang C. Angiotensin-(1-7) mitigated angiotensin II-induced abdominal aortic aneurysms in apolipoprotein E-knockout mice. Br J Pharmacol. 2020 Apr;177(8):1719-1734. doi: 10.1111\/bph.14906. Epub 2020 Mar 2. PMID: 31658493; PMCID: PMC7070176.","DOI":"10.1111\/bph.14906"},{"key":"10.1016\/j.bcp.2024.116062_b0515","doi-asserted-by":"crossref","unstructured":"Sharma N, Belenchia AM, Toedebusch R, Pulakat L, Hans CP. AT2R agonist NP-6A4 mitigates aortic stiffness and proteolytic activity in mouse model of aneurysm. J Cell Mol Med. 2020 Jul;24(13):7393-7404. doi: 10.1111\/jcmm.15342. Epub 2020 May 18. PMID: 32420690; PMCID: PMC7339180.","DOI":"10.1111\/jcmm.15342"},{"issue":"6027","key":"10.1016\/j.bcp.2024.116062_b0520","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism","volume":"332","author":"Habashi","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0525","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/HJH.0000000000000845","article-title":"AT1-receptor blockade, but not renin inhibition, reduces aneurysm growth and cardiac failure in fibulin-4 mice","volume":"34","author":"Te Riet","year":"2016","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.bcp.2024.116062_b0530","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/FJC.0000000000000560","article-title":"The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome","volume":"71","author":"Verbrugghe","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116062_b0535","doi-asserted-by":"crossref","unstructured":"Tieu BC, Ju X, Lee C, Sun H, Lejeune W, Recinos A 3rd, Brasier AR, Tilton RG. Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling. J Vasc Res. 2011;48(3):261-72. doi: 10.1159\/000320358. Epub 2010 Nov 23. PMID: 21099231; PMCID: PMC2997450.","DOI":"10.1159\/000320358"},{"key":"10.1016\/j.bcp.2024.116062_b0540","doi-asserted-by":"crossref","unstructured":"K\u00fcnzli M, Masopust D. CD4+T cell memory. Nat Immunol. 2023 Jun;24(6):903-914. doi: 10.1038\/s41590-023-01510-4. Epub 2023 May 8. PMID: 37156885; PMCID: PMC10343737.","DOI":"10.1038\/s41590-023-01510-4"},{"issue":"2","key":"10.1016\/j.bcp.2024.116062_b0545","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9440(10)64206-X","article-title":"T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm","volume":"161","author":"Sch\u00f6nbeck","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2024.116062_b0550","doi-asserted-by":"crossref","unstructured":"Shimada K, Furukawa H, Wada K, Wei Y, Tada Y, Kuwabara A, Shikata F, Kanematsu Y, Lawton MT, Kitazato KT, Nagahiro S, Hashimoto T. Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice. J Cereb Blood Flow Metab. 2015 Jul;35(7):1163-8. doi: 10.1038\/jcbfm.2015.30. Epub 2015 Mar 11. PMID: 25757758; PMCID: PMC4640268.","DOI":"10.1038\/jcbfm.2015.30"},{"issue":"7","key":"10.1016\/j.bcp.2024.116062_b0555","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/ATVBAHA.108.180760","article-title":"Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB","volume":"29","author":"Aoki","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0560","first-page":"103","article-title":"Conditional expression of type 2 angiotensin II receptor in rat vascular smooth muscle cells reveals the interplay of the angiotensin system in matrix metalloproteinase 2 expression and vascular remodeling","volume":"24","author":"Jing","year":"2009","journal-title":"Int. J. Mol. Med."},{"issue":"13","key":"10.1016\/j.bcp.2024.116062_b0565","article-title":"Association of TGF-\u03b2 Canonical Signaling-Related Core Genes With Aortic Aneurysms and Aortic Dissections","volume":"20","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116062_b0570","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.kint.2018.07.028","article-title":"AT2 receptor stimulation inhibits phosphate-induced vascular calcification","volume":"95","author":"Kukida","year":"2019","journal-title":"Kidney Int."},{"issue":"26","key":"10.1016\/j.bcp.2024.116062_b0575","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"43","key":"10.1016\/j.bcp.2024.116062_b0580","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1093\/eurheartj\/ehaa377","article-title":"Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial","volume":"41","author":"van Andel","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2024.116062_b0585","doi-asserted-by":"crossref","unstructured":"Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S, Huang J, Offenstadt G, Combadi\u00e8re C, R\u00e9nia L, Johnson JL, Tharaux PL, Tedgui A, Mallat Z. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest. 2010 Feb;120(2):422-32. doi: 10.1172\/JCI38136. Epub 2010 Jan 25. PMID: 20101093; PMCID: PMC2810071.","DOI":"10.1172\/JCI38136"},{"key":"10.1016\/j.bcp.2024.116062_b0590","doi-asserted-by":"crossref","unstructured":"Gao F, Chambon P, Offermanns S, Tellides G, Kong W, Zhang X, Li W. Disruption of TGF-\u03b2 signaling in smooth muscle cell prevents elastase-induced abdominal aortic aneurysm. Biochem Biophys Res Commun. 2014 Nov 7;454(1):137-43. doi: 10.1016\/j.bbrc.2014.10.053. Epub 2014 Oct 18. Erratum in: Biochem Biophys Res Commun. 2015 May 8;460(3):887. PMID: 25450370.","DOI":"10.1016\/j.bbrc.2015.04.001"},{"issue":"12","key":"10.1016\/j.bcp.2024.116062_b0595","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/HJH.0b013e328313e547","article-title":"Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation","volume":"26","author":"Kaschina","year":"2008","journal-title":"J. Hypertens."},{"issue":"15","key":"10.1016\/j.bcp.2024.116062_b0600","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1042\/CS20170131","article-title":"AT1-receptor blockade attenuates outward aortic remodeling associated with diet-induced obesity in mice","volume":"131","author":"Krueger","year":"2017","journal-title":"Clin. Sci. (Lond.)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T08:50:52Z","timestamp":1717836652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":120,"alternative-id":["S0006295224000455"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116062","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin AT2 receptors reduce inflammation and fibrosis in cardiovascular remodeling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116062"}}